Question
upstudy study bank question image url

A patient with Parkinson’s disease would be most likely to take which class of medication to treat their symptoms?
a. acetylcholinesterase inhibitors
b. dopaminergic drugs
c. phosphodiesterase inhibitors
d. alpha blockers

Ask by Turnbull Bowen. in the United States
Dec 08,2024

Upstudy AI Solution

Tutor-Verified Answer

Answer

The patient would likely take b. dopaminergic drugs.

Solution

A patient with Parkinson’s disease would be most likely to take b. dopaminergic drugs to treat their symptoms. Dopaminergic drugs, such as levodopa, are commonly used to help manage the motor symptoms associated with Parkinson’s disease by increasing dopamine levels in the brain.

Answered by UpStudy AI and reviewed by a Professional Tutor

error msg
Explain
Simplify this solution

Mind Expander

Dopaminergic drugs are the go-to class of medication for treating symptoms of Parkinson’s disease. This is because Parkinson’s affects the brain’s ability to produce dopamine, a critical neurotransmitter that helps regulate movement. Medications such as Levodopa aim to replenish dopamine levels, providing significant relief from motor symptoms.
To add a twist, did you know that the first use of Levodopa goes back to the 1960s? It transformed Parkinson’s treatment and opened the door to further research! Patients experienced remarkable improvements in their motor functions, making it a milestone in managing this chronic disorder and enhancing the quality of life for many.

Try Premium now!
Try Premium and ask Thoth AI unlimited math questions now!
Maybe later Go Premium
Study can be a real struggle
Why not UpStudy it?
Select your plan below
Premium

You can enjoy

Start now
  • Step-by-step explanations
  • 24/7 expert live tutors
  • Unlimited number of questions
  • No interruptions
  • Full access to Answer and Solution
  • Full Access to PDF Chat, UpStudy Chat, Browsing Chat
Basic

Totally free but limited

  • Limited Solution
Welcome to UpStudy!
Please sign in to continue the Thoth AI Chat journey
Continue with Email
Or continue with
By clicking “Sign in”, you agree to our Terms of Use & Privacy Policy